Novozymes A/S (NVZMY) Stock Chart & Stock Price History $69.75 -0.68 (-0.97%) As of 05/23/2025 03:59 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartDividendHeadlinesSEC FilingsShort InterestBuy This Stock Novozymes A/S Stock Price Performance The Novozymes A/S (NVZMY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 13.30%, with a year-to-date return of 23.36%. In the past month, the stock has increased 9.14%, reflecting recent market activity. As of the latest close, Novozymes A/S traded at $69.75 with a market cap of $32.66 billion and volume of 157,383 shares. Five years ago, the stock traded at $51.39, representing a 35.73% increase over that period. At the time, it had a market cap of $15.26 billion and a volume of 28,184 shares. Receive NVZMY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.19%1 Month Performance+9.14%3 Month Performance+22.43%Year-To-Date Performance+23.36%1 Year Performance+13.30%5 Year Performance+35.73% NVZMY Stock Chart for Sunday, May, 25, 2025 NVZMY Chart by TradingView Novozymes A/S Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/23/2025$70.43$69.75-0.97%$70.86$69.05157,383 shs$32.66 billion05/22/2025$70.09$70.43+0.49%$70.43$69.8112,234 shs$32.98 billion05/21/2025$68.93$70.09+1.68%$70.65$69.397,843 shs$32.82 billion05/20/2025$68.44$68.93+0.72%$68.93$67.468,096 shs$32.28 billion05/19/2025$68.49$68.44-0.07%$70.17$66.8513,938 shs$32.05 billion05/16/2025$67.12$68.49+2.04%$68.50$65.394,852 shs$32.07 billion05/15/2025$66.30$67.12+1.24%$68.80$66.0512,195 shs$31.43 billion05/14/2025$66.00$66.30+0.45%$68.32$65.517,024 shs$31.05 billion05/13/2025$65.28$66.00+1.10%$66.06$63.3813,015 shs$30.91 billion05/12/2025$67.12$65.28-2.74%$67.44$62.8612,665 shs$30.57 billion Get the Latest News and Ratings for NVZMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter. 05/09/2025$67.08$67.12+0.06%$68.00$66.1353,665 shs$31.43 billion05/08/2025$64.66$67.08+3.74%$67.94$65.2112,141 shs$31.41 billion05/07/2025$65.19$64.66-0.81%$65.65$62.9510,449 shs$30.28 billion05/06/2025$65.50$65.19-0.47%$65.43$62.9010,072 shs$30.53 billion05/05/2025$65.70$65.50-0.30%$66.59$64.6013,508 shs$30.67 billion05/02/2025$66.04$65.70-0.51%$67.50$64.219,958 shs$30.77 billion05/01/2025$64.91$66.04+1.74%$67.07$62.5015,150 shs$30.93 billion04/30/2025$63.53$64.91+2.17%$66.46$63.5319,692 shs$30.40 billion04/29/2025$62.99$63.53+0.86%$65.00$62.676,322 shs$29.75 billion04/28/2025$63.91$62.99-1.44%$64.37$60.6712,441 shs$29.50 billion04/25/2025$63.16$63.91+1.19%$64.33$60.754,440 shs$29.93 billion04/24/2025$62.29$63.16+1.40%$64.72$60.808,120 shs$29.58 billion Related Companies argenx Stock Chart BioNTech Stock Chart Biogen Stock Chart Neurocrine Biosciences Stock Chart Exelixis Stock Chart Moderna Stock Chart Qiagen Stock Chart Bio-Techne Stock Chart Revolution Medicines Stock Chart Repligen Stock Chart Receive NVZMY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:NVZMY) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novozymes A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novozymes A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVZMY Stock Free NVZMY Stock Alerts